An official website of the United States government.

This is not the current EPA website. To navigate to the current EPA website, please go to www.epa.gov. This website is historical material reflecting the EPA website as it existed on January 19, 2021. This website is no longer updated and links to external websites and some internal pages may not work. More information »

Environmental Sampling and Analytical Methods (ESAM) Program

SAM Pathogen Methods

Selected Analytical Methods for Environmental Remediation and Recovery (SAM) provides a list of methods or procedures to be used in analyzing environmental samples for pathogens. Following a microbial contamination incident, it is assumed that the identification, confirmation and strain-level characterization of the pathogen have been completed before the U.S. Environmental Protection Agency’s (EPA) remediation actions begin. The first phase of EPA’s actions includes site characterization, to determine the extent and magnitude of contamination and to guide remediation planning. Based on the results of sample analyses for site characterization, EPA will determine the approach for site decontamination. During the post decontamination (clearance) phase of remediation, samples are collected and analyzed to determine the efficacy of the decontamination treatment.

Selection of methods should be based on specific data and information needs, including consideration of the remediation phase and whether there is a need to determine either the presence of a pathogen, the viability of a pathogen or both.

The flow chart in Figure 7-1 presents a summary of the sample types, overall steps in sample analysis, and analytical techniques that should be used to address pathogens during EPA site remediation activities following a contamination incident. For Pathogens, site characterization refers to the assessment phase, decontamination refers to the cleanup phase and post decontamination refers to the clearance phase.

Methods for Site Characterization Phase: Since decontamination of the affected site has to quickly follow the site characterization phase, rapid analytical methods should be selected to determine the extent and magnitude of contamination. It is assumed here that, prior to site characterization, the identity and viability of the pathogen have been determined. Therefore, in most cases, the analytical methods selected for site characterization may not have to determine the viability of the pathogen. The methods should also provide a high throughput analytical capability, so that a large number of samples can be rapidly analyzed to determine the presence or absence of the pathogen and allow for site decontamination planning in a time-efficient manner. For most pathogens, such methods routinely include polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA) or other immunoassay-based methods. Depending on the pathogen, type of incident and response, culture methods could be appropriate for use during site characterization. In certain cases, the determination of the extent of pathogen contamination within this phase may drive decontamination planning.

Methods for Post Decontamination Phase: It is extremely critical that the analytical methods used during post decontamination be highly sensitive, specific, rapid and able to determine pathogen viability. For post decontamination phase samples, neutralization or removal of the decontamination agent may be required prior to analysis to minimize false negative results. Traditional microbiological culture methods typically include plating on selective medium to determine the viability of the pathogen and to minimize or eliminate non-target growth. The absence of growth on the medium generally indicates the absence of live pathogen in the sample (with the exception of some pathogens which may become viable but non-culturable [VBNC]). To minimize the analytical time needed to obtain results, typical colonies should be quickly analyzed to confirm the presence of the pathogen using reliable and rapid methods such as PCR, ELISA or other immunoassay-based methods, as opposed to time and labor intensive traditional biochemical and serological procedures.

Please note: SAM provides guidance for selecting pathogen methods that have a high likelihood of assuring analytical consistency when laboratories analyze a large number of samples during remediation. Not all methods have been verified for the pathogen/sample type combination. Please refer to the specified method to identify analyte/sample type combinations for which the method has been verified. Any questions regarding this information should be addressed to the appropriate Technical Contact(s).

Pathogens that require biosafety level (BSL)-4 containment and practices, such as hemorrhagic fever viruses and Variola major (smallpox) will be handled only by reference laboratories with BSL-4 capability and are not included in this document. All other pathogens should be handled using BSL-2 or BSL-3 containment and practices, as appropriate. Pathogens that are considered to be solely of agricultural concern (i.e., animal and plant pathogens) are not currently included. However, such pathogens may be considered for possible inclusion in future SAM updates.

Although culture-based methods have been selected for many of the pathogens, due to technical difficulty and time constraints, molecular techniques such as PCR will likely be used for viruses. Some of the selected methods include multiple analytical techniques by inference. The analytical technique listed for each pathogen is intended to be a description of the predominant technique that is required to provide the data quality parameter (viability or detection and identification). This description does not preclude the use of other techniques that are within or referenced by the method. For example, a viability method or procedure listed as “culture” might include immunochemical or PCR- based assays for the identification and/or confirmation of isolates. Several of the methods also include options such as the use of multiple cell culture media for primary isolation and a selection of a defined subset of biochemical tests for confirmation. To expedite time-to-results, however, isolates should be confirmed using rapid techniques (e.g., PCR, ELISA).

Sample Processing: It is widely recognized in the scientific community that the processing of biologically contaminated environmental samples is one of the most challenging issues prior to sample analysis. Although details regarding sample processing are not included, it is critical that end users and stakeholders select the most appropriate sample processing procedure for a given sample type and analytical method. It is highly unlikely that a single procedure will be applicable to all sample types and analytical methods. Inadequate sample processing may not only decrease recovery efficiency of biological targets (e.g., pathogen, deoxyribonucleic acid/ribonucleic acid [DNA/RNA], antigen/protein) from the samples, but also prevent accurate quantitation and high throughput. Samples should not be stored indefinitely, and should be processed and analyzed as soon as possible upon receipt. Note: For post decontamination samples it may be necessary to neutralize the decontamination agent.

The selected methods attempt to address multiple environmental sample types, each with different physical, chemical and biological properties (e.g., pH, inhibitory substances and background microorganisms). In this edition of SAM, emphasis is given to the environmental sample types that are predominately used to fulfill EPA’s responsibilities following a contamination incident (e.g., aerosols, particulates [wipes or swabs], soils, drinking water, post decontamination waste water). Other sample types may have to be analyzed and, for those sample types, specific requests should be sent to the Pathogen Methods Lead and Alternate Lead. See: SAM Technical Contacts.

Below is a list of all selected pathogen methods with a link to their source. Due to the complexity of some tables and graphics, some of our information is not amenable to a screen reader. If you have trouble accessing information contact Kathleen Nickel (nickel.kathy@epa.gov) and accommodations will be made.

You may need a PDF reader to view some of the files on this page. See EPA’s About PDF page to learn more.

Pathogen

Technique

Method

Bacillus anthracis

Sample Preparation

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA/600/R-12/577

Bacillus anthracis

Real-Time PCR, RV PCR and Culture (B. anthracis)

EPA/600/R-12/577

Brucella spp. [Brucellosis]

Sample Preparation

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA/600/R-16/109

Journal of Microbiological Methods (2008) 75(2): 375-378 Exit

Brucella spp. [Brucellosis]

Real-Time PCR (Brucella)

Journal of Microbiological Methods (2008) 75(2): 375-378 Exit

Brucella spp. [Brucellosis]

Culture (Brucella)

ASM Sentinel Level Clinical Microbiology Laboratory Guidelines: Brucella species 

Burkholderia mallei [Glanders] and Burkholderia pseudomallei [Melioidosis]

Sample Preparation

PLoS Neglected Tropical Diseases (2013) 7(3): e2105 Exit

EPA/600/R-16/109

Burkholderia mallei [Glanders] and Burkholderia pseudomallei [Melioidosis]

Real-Time PCR (Burkholderia mallei and Burkholderia pseudomallei)

Clinical Chemistry (2006) 52(2): 307-310 (PDF) Exit

Journal of Clinical Microbiology (2006) 44(1): 85-90 (PDF) Exit

Burkholderia mallei [Glanders] and Burkholderia pseudomallei [Melioidosis]

Culture (Burkholderia mallei and Burkholderia pseudomallei)

ASM Sentinel Level Clinical Laboratory Guidelines: Burkholderia mallei and B. pseudomallei (PDF) Exit

Campylobacter jejuni [Campylobacteriosis]

Sample Preparation

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA/600/R-16/109

Journal of Clinical Microbiology (2010) 48(8): 2929-2933 (PDF) Exit

Campylobacter jejuni [Campylobacteriosis]

Real-Time PCR (Campylobacter)

Journal of Clinical Microbiology (2010) 48(8): 2929-2933 (PDF) Exit

Culture (Campylobacter)

ISO 17995 Exit

Chlamydophila psittaci [Psittacosis] (formerly known as Chlamydia psittaci)

Sample Preparation

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA/600/R-16/109

Journal of Clinical Microbiology (2000) 38(3): 1085-1093 (PDF) Exit

Chlamydophila psittaci [Psittacosis] (formerly known as Chlamydia psittaci)

 Tissue Culture and PCR (Chlamydophila)

Journal of Clinical Microbiology (2000) 38(3): 1085-1093 (PDF) Exit

Coxiella burnetii

[Q-fever]

Sample Preparation

EPA/600/R-12/577

Applied Environmental Microbiology (2011) 77(23): 8355-8359 (PDF) Exit

Journal of Microbiological Methods (2010) 81(2): 141-146 Exit

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA 600/R-11/103

BMC Microbiology (2008) 8:77 Exit

Coxiella burnetii

[Q-fever]

Real-Time PCR (Coxiella)

BMC Microbiology (2008) 8:77 Exit

Coxiella burnetii

[Q-fever]

Tissue Culture (Coxiella)

 Antimicrobial Agents and Chemotherapy (1991) 35(10): 2070-2077 Exit

Escherichia coli O157:H7

Sample Preparation

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA/600/R-10/056
(52 pp, 747 K, About PDF)

EPA/600/R-16/109

Environmental Science and Technology (2011) 45(6): 2250-2256 Exit

Escherichia coli O157:H7

Real-Time PCR (E. coli O157:H7)

Environmental Science and Technology (2011) 45(6): 2250-2256 Exit

Escherichia coli O157:H7

Culture (E. coli O157:H7)

EPA/600/R-10/056
(52 pp, 747 K, About PDF)

Francisella tularensis [Tularemia]

Sample Preparation

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA/600/R-16/109

Journal of Clinical Microbiology (2003) 41(12): 5492-5499 (PDF) Exit

Applied and Environmental Microbiology (2011) 77(18): 6729-6732 (PDF) Exit

Francisella tularensis [Tularemia]

Real-Time PCR (Francisella)

Journal of Clinical Microbiology (2003) 41(12): 5492-5499 (PDF) Exit

Francisella tularensis [Tularemia]

Culture (Francisella)

CDC, ASM and APHL (2001) Sentinel Level Clinical Microbiology Laboratory Guidelines: Francisella tularensis (PDF) Exit

Legionella pneumophila [Legionellosis]

Sample Preparation

Procedures for the Recovery of Legionella from the Environment

Methods in Molecular Biology (2013) 954: 3-25

EPA/600/R-16/109

Journal of Clinical Microbiology (2013) 51(1): 348-351

Legionella pneumophila [Legionellosis]

Real-Time PCR (Legionella)

Journal of Clinical Microbiology (2013) 51(1): 348-351

Legionella pneumophila [Legionellosis]

Culture (Legionella)

Methods in Molecular Microbiology (2013) 954: 3-25

Leptospira interrogans [Leptospirosis]

Sample Preparation

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA/600/R-16/109

Molecular and Cellular Probes (2005) 19(2): 111-117 Exit

Leptospira interrogans [Leptospirosis]

Real-Time PCR (Leptospira)

Molecular and Cellular Probes (2005) 19(2): 111-117 Exit

Leptospira interrogans [Leptospirosis]

Culture (Leptospira)

Standard Method 9260 I Exit

Listeria monocytogenes [Listeriosis]

Sample Preparation

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA/600/R-16/109

USDA Microbiology Laboratory Guidebook, Chapter MLG 8A.04 (2009)

Listeria monocytogenes [Listeriosis]

Real-Time PCR (Listeria)

USDA Microbiology Laboratory Guidebook, Chapter MLG 8A.04 (2009)

Listeria monocytogenes [Listeriosis]

Culture (Listeria)

Bacteriological Analytical Manual Online, Chapter 10

Non-typhoidal Salmonella [Salmonellosis] (Not applicable to S. typhi)

Sample Preparation

EPA Method 1682

EPA Method 1200

Standard Method 9260B Exit

EPA/600/R-16/109

Environmental Science and Technology (2011) 45(20): 8996-9002 Exit

Non-typhoidal Salmonella [Salmonellosis] (Not applicable to S. typhi)

Real-Time PCR (Non-typhoidal Salmonella)

Environmental Science and Technology (2011) 45(20): 8996-9002 Exit

Non-typhoidal Salmonella [Salmonellosis] (Not applicable to S. typhi)

Culture (Non-typhoidal Salmonella)

EPA Method 1200

EPA Method 1682

Salmonella enterica serovar Typhi [Typhoid fever]

Sample Preparation

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA 600/R-10/133

Standard Method 9260B Exit

EPA/600/R-16/109

CDC Laboratory Assay. Triplex PCR for Detection of S. Typhi Using Smart Cycler®

Salmonella enterica serovar Typhi [Typhoid fever]

Real-Time PCR (Salmonella Typhi)

CDC Laboratory Assay. Triplex PCR for Detection of S. Typhi Using Smart Cycler®

Salmonella enterica serovar Typhi [Typhoid fever]

Culture (Salmonella Typhi)

EPA/600/R-16/109

Shigella spp. [Shigellosis]

Sample Preparation

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA/600/R-16/109

Journal of Clinical Microbiology (2010) 48(8): 2929-2933 (PDF) Exit

Shigella spp. [Shigellosis]

Real-Time PCR (Shigella)

Journal of Clinical Microbiology (2010) 48(8): 2929-2933 (PDF) Exit

EPA/600/R-16/109

Shigella spp. [Shigellosis]

Culture (Shigella)

SM Method 9260 Exit

Staphylococcus aureus

Sample Preparation

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA/600/R-16/109

Journal of Food Protection (2007) 70(12): 2855-2859 Exit

Staphylococcus aureus

Real-Time PCR (Staphylococcus)

Journal of Food Protection (2007) 70(12): 2855-2859 Exit

Staphylococcus aureus

Culture (Staphylococcus)

SM 9213 B Exit

Vibrio cholerae [Cholera]

Sample Preparation

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA/600/R-16/109

EPA 600/R-10/139
(56 pp, 1000 K, About PDF)

Journal of Microbiological Methods (2007) 68(2): 254-259 Exit

Vibrio cholerae [Cholera]

Real-Time PCR (Vibrio)

Journal of Microbiological Methods (2007) 68(2): 254-259 Exit

Vibrio cholerae [Cholera]

Culture and Real-Time PCR (Vibrio)

EPA 600/R-10/139
(56 pp, 1000 K, About PDF)

Yersinia pestis [Plague]

Sample Preparation

Journal of Microbiological Methods (2016) 130: 6-13 Exit

EPA/600/R-16/109

Yersinia pestis [Plague]

Real-Time PCR, RV-PCR and Culture (Yersinia)

EPA/600/R-16/109

Adenoviruses: Enteric and non-enteric (A-F)

Sample Preparation

Journal of Environmental Monitoring (2011) 13: 3321-3328 Exit

Applied and Environmental Microbiology (2015) 81(17): 5987-5992 (PDF) Exit

Applied and Environmental Microbiology (2005) 71(6): 3119-3125

EPA 600/R-11/103

EPA Method 1615

Applied and Environmental Microbiology (2005) 71(6): 3131-3136 (PDF) Exit

Adenoviruses: Enteric and non-enteric (A-F)

Real-Time PCR (Adenoviruses)

Applied and Environmental Microbiology (2005) 71(6): 3131-3136 (PDF) Exit

Adenoviruses: Enteric and non-enteric (A-F)

Tissue Culture (Adenoviruses)

Journal of Microbiological Methods (2016) 122: 43-49 Exit

Astroviruses

Sample Preparation

Journal of Environmental Monitoring (2011) 13: 3321-3328 Exit

Applied and Environmental Microbiology (2015) 81(17): 5987-5992 (PDF) Exit

Applied and Environmental Microbiology (2005) 71(6): 3119-3125 Exit

EPA 600/R-11/103

EPA Method 1615

Canadian Journal of Microbiology (2004) 50(4): 269-278 Exit

Astroviruses

Real-Time Reverse Transcription- PCR (Astroviruses)

Canadian Journal of Microbiology (2004) 50(4): 269-278 Exit

Astroviruses

Integrated Cell Culture (Astroviruses)

Canadian Journal of Microbiology (2004) 50(4): 269-278 Exit

Caliciviruses: Noroviruses

Sample Preparation

Journal of Environmental Monitoring (2011) 13: 3321-3328 Exit

Applied and Environmental Microbiology (2015) 81(17): 5987-5992 (PDF) Exit

Applied and Environmental Microbiology (2005) 71(6): 3119-3125 Exit

EPA 600/R-11/103

EPA Method 1615

Caliciviruses: Noroviruses

Real-Time Reverse Transcription-PCR (Noroviruses)

EPA Method 1615

Caliciviruses: Saporovirus

Sample Preparation

Journal of Environmental Monitoring (2011) 13: 3321-3328 Exit

Applied and Environmental Microbiology (2015) 81(17): 5987-5992 (PDF) Exit

Applied and Environmental Microbiology (2005) 71(6): 3119-3125

EPA 600/R-11/103

EPA Method 1615

Caliciviruses: Saporovirus

Real-Time Reverse Transcription-PCR (Caliciviruses-Saporovirus)

Journal of Medical Virology (2006) 78(10): 1347-1353 Exit

Caliciviruses: Saporovirus

Tissue Culture (Caliciviruses-Saporovirus)

Archives of Virology (1991) 120(1-2): 115-122 Exit

Coronaviruses: Severe Acute Respiratory Syndrome (SARS) -associated Human Coronavirus (HCoV)

Sample Preparation

Journal of Environmental Monitoring (2011) 13: 3321-3328 Exit

Applied and Environmental Microbiology (2015) 81(17): 5987-5992 (PDF) Exit

Applied and Environmental Microbiology (2005) 71(6): 3119-3125

EPA 600/R-11/103

EPA Method 1615

Journal of Virological Methods (2004) 122(1): 29-36 Exit

Coronaviruses: Severe Acute Respiratory Syndrome (SARS) -associated Human Coronavirus (HCoV)

Reverse Transcription-PCR (SARS-HCoV)

Journal of Virological Methods (2004) 122(1): 29-36 Exit

Coronaviruses: Severe Acute Respiratory Syndrome (SARS) -associated Human Coronavirus (HCoV)

Tissue Culture (SARS-HCoV)

Applied Biosafety (2007) 12(2): 100-108 (PDF) Exit

Hepatitis E virus [HEV]

Sample Preparation

Journal of Environmental Monitoring (2011) 13: 3321-3328 Exit

Applied and Environmental Microbiology (2015) 81(17): 5987-5992 (PDF) Exit

Applied and Environmental Microbiology (2005) 71(6): 3119-3125

EPA 600/R-11/103

EPA Method 1615

Journal of Virological Methods (2006) 131(1): 65-71 Exit

Hepatitis E virus [HEV]

Real-Time Reverse Transcription-PCR (Hepatitis E)

Journal of Virological Methods (2006) 131(1): 65-71 Exit

Hepatitis E virus [HEV]

Tissue Culture

(Hepatitis E)

FEMS Immunology Medical Microbiology (2009) 56(1): 73-79 (PDF) Exit

Influenza H5N1 virus

Sample Preparation

Applied and Environmental Microbiology (2006) 72(7): 4811-4818 Exit

Applied and Environmental Microbiology (2015) 81(17): 5987-5992 (PDF) Exit

Applied and Environmental Microbiology (2005) 71(6): 3119-3125

EPA 600/R-11/103

EPA Method 1615

Emerging Infectious Diseases (2005) 11(8): 1303-1305

Influenza H5N1 virus

Real-Time Reverse Transcription-PCR (Influenza H5N1)

Emerging Infectious Diseases (2005) 11(8): 1303-1305

Influenza H5N1 virus

Tissue Culture

(Influenza H5N1)

Methods in Molecular Biology (2012) 865: 11-24

Picornaviruses: Enteroviruses

Sample Preparation

Journal of Environmental Monitoring (2011) 13: 3321-3328 Exit

Applied and Environmental Microbiology (2015) 81(17): 5987-5992 (PDF) Exit

Applied and Environmental Microbiology (2005) 71(6): 3119-3125

EPA 600/R-11/103

EPA Method 1615

Picornaviruses: Enteroviruses

Real-Time Reverse Transcription-PCR and Tissue Culture (Enteroviruses)

EPA Method 1615

Picornaviruses: Hepatitis A virus [HAV]

Sample Preparation

Journal of Environmental Monitoring (2011) 13: 3321-3328 Exit

Applied and Environmental Microbiology (2015) 81(17): 5987-5992 (PDF) Exit

Applied and Environmental Microbiology (2005) 71(6): 3119-3125

EPA 600/R-11/103

EPA Method 1615

Journal of Food Protection (2011) 74(10): 1756-1761

Picornaviruses: Hepatitis A virus [HAV]

Real-Time Reverse Transcription-PCR and Integrated Cell Culture (Hepatitis A)

Journal of Food Protection (2011) 74(10): 1756-1761

Reoviruses: Rotavirus (Group A)

Sample Preparation

Journal of Environmental Monitoring (2011) 13: 3321-3328 Exit

Applied and Environmental Microbiology (2015) 81(17): 5987-5992 (PDF) Exit

Applied and Environmental Microbiology (2005) 71(6): 3119-3125

EPA 600/R-11/103

EPA Method 1615

Journal of Virological Methods (2009) 155(2): 126-131 Exit

Reoviruses: Rotavirus (Group A)

Real-Time Reverse Transcription-PCR (Rotavirus)

Journal of Virological Methods (2009) 155(2): 126-131 Exit

Reoviruses: Rotavirus (Group A)

Tissue Culture (Rotavirus)

EPA Method 1615

Cryptosporidium spp. [Cryptosporidiosis]

Sample Preparation

EPA/600/R-12/577

Journal of Microbiological Methods (2010) 81(2): 141-146 Exit

Applied and Environmental Microbiology (2011) 77(23): 8355-8359 (PDF) Exit

Applied and Environmental Microbiology (2011) 77(18): 6476-6485 Exit

EPA Method 1622

EPA Method 1623.1

EPA 600/R-11/103

Applied and Environmental Microbiology (2011) 69(9): 5178-5185 (PDF) Exit

Applied and Environmental Microbiology (2011) 71(3): 1135-1141 (PDF) Exit

Cryptosporidium spp. [Cryptosporidiosis]

Real-Time PCR (Cryptosporidium)

Applied and Environmental Microbiology (2011) 69(9): 5178-5185 (PDF) Exit

Applied and Environmental Microbiology (2011) 71(3): 1135-1141 (PDF) Exit

Cryptosporidium spp. [Cryptosporidiosis]

Immunomagnetic Separation/Fluorescence Assay (Cryptosporidium)

EPA Method 1622

EPA Method 1623.1

Cryptosporidium spp. [Cryptosporidiosis]

Cell Culture Immunofluorescence (Cryptosporidium)

Canadian Journal of Microbiology (2007) 53(5): 656-663 Exit

Entamoeba histolytica

Sample Preparation

EPA/600/R-12/577

Journal of Microbiological Methods (2010) 81(2): 141-146 Exit

Applied and Environmental Microbiology (2011) 77(23): 8355-8359 (PDF) Exit

Applied and Environmental Microbiology (2011) 77(18): 6476-6485 Exit

EPA 600/R-11/103

Journal of Clinical Microbiology (2005) 43(5): 2168-2172 (PDF) Exit

Entamoeba histolytica

Real-Time PCR (Entamoeba histolytica)

Journal of Clinical Microbiology (2005) 43(5): 2168-2172 (PDF) Exit

Entamoeba histolytica

Cell Culture (Entamoeba histolytica)

Journal of Parasitology (1972) 58(2): 306-310 Exit

Giardia spp. [Giardiasis]

Sample Preparation

EPA/600/R-12/577

Journal of Microbiological Methods (2010) 81(2): 141-146 Exit

Applied and Environmental Microbiology (2011) 77(23): 8355-8359 (PDF) Exit

Applied and Environmental Microbiology (2011) 77(18): 6476-6485 Exit

EPA 600/R-11/103

EPA Method 1623.1

Applied and Environmental Microbiology (2003) 69(9): 5178-5185 (PDF) Exit

Giardia spp. [Giardiasis]

Real-Time PCR (Giardia)

Applied and Environmental Microbiology (2003) 69(9): 5178-5185 (PDF) Exit

Giardia spp. [Giardiasis]

Immunomagnetic Separation/Fluorescence Assay (Giardia)

EPA Method 1623.1

Giardia spp. [Giardiasis]

Cell Culture (Giardia)

Transactions of the Royal Society of Tropical Medicine and Hygiene (1983) 77(4): 487-488 Exit

Naegleria fowleri [Naegleriasis] [Giardiasis]

Sample Preparation

EPA/600/R-12/577

Journal of Microbiological Methods (2010) 81(2): 141-146 Exit

Applied and Environmental Microbiology (2011) 77(23): 8355-8359 (PDF) Exit

Journal of Parasitology Research (2013) ID 608367: 8 pages Exit

Clinical Infectious Diseases (2015) 60(8): e36-42

EPA 600/R-11/103

Naegleria fowleri [Naegleriasis] [Giardiasis]

Real-Time PCR and Culture (Naegleria)

Journal of Parasitology Research (2013) ID 608367: 8 pages Exit

Toxoplasma gondii [Toxoplasmosis]

Sample Preparation

EPA/600/R-12/577

Journal of Microbiological Methods (2010) 81(2): 141-146 Exit

Applied and Environmental Microbiology (2011) 77(23): 8355-8359 (PDF) Exit

Applied and Environmental Microbiology (2011) 77(18): 6476-6485 Exit

Journal of Microbiological Methods (2010) 81(3): 219-225 Exit

Applied and Environmental Microbiology (2009) 75(11): 3477-3483 (PDF) Exit

Toxoplasma gondii [Toxoplasmosis]

Real-Time PCR (Toxoplasma)

Applied and Environmental Microbiology (2009) 75(11): 3477-3483 (PDF) Exit

Toxoplasma gondii [Toxoplasmosis]

Cell Culture (Toxoplasma)

Journal of Microbiological Methods (2010) 81(3): 219-225 Exit

Baylisascaris procyonis [Raccoon roundworm fever]

Sample Preparation

EPA/600/R-12/577

Journal of Microbiological Methods (2010) 81(2): 141-146 Exit

Applied and Environmental Microbiology (2011) 77(23): 8355-8359 (PDF) Exit

Applied and Environmental Microbiology (2011) 77(18): 6476-6485 Exit

EPA 600/R-11/103

Parasitology Research (2010) 106: 499-504 Exit

Baylisascaris procyonis [Raccoon roundworm fever]

Real-Time PCR (Baylisascaris)

Parasitology Research (2010) 106: 499-504

Baylisascaris procyonis [Raccoon roundworm fever]

Embryonation of Eggs and Microscopy (Baylisascaris)

EPA/625/R-92/013

Top of Page